GSK-1070916, CAS [[942918-07-2]]

Produktübersicht

• Artikelname: GSK-1070916, CAS [[942918-07-2]]
• Artikelnummer: TGM-T6129
• Hersteller Artikelnummer: T6129
• Alternativnummer: TGM-T6129-1MLX10MM(INDMSO),TGM-T6129-1MG,TGM-T6129-5MG,TGM-T6129-10MG,TGM-T6129-25MG,TGM-T6129-50MG,TGM-T6129-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: GSK-1070916A , GSK1070916

Produktbeschreibung

GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1.

Produkteigenschaften

• Molekulargewicht: 507.63
• Reinheit: 99.73%
• CAS Nummer: [942918-07-2]
• Formel: C30H33N7O
• Target-Kategorie: Aurora Kinase|||AMPK|||FLT|||Apoptosis|||Tie-2

Bilder

T6129